{"entity":{"type":"insider","cik":"0001727807","url":"/insider/0001727807","json_url":"/insider/0001727807.json","name":"Elliott Russell P.","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":4,"n_filings":4,"first":"2018-03-06","last":"2018-10-02","span_basis":"filed_date"},"name_variants":[{"name":"Elliott Russell P.","source":"filing","n_filings":4,"first_seen":"2018-03-06","last_seen":"2018-10-02"}],"transactions":[{"id":6122007,"accession":"0001178913-18-002611","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001178913-18-002611","line_url":"/filing/0001178913-18-002611#line-1","is_derivative":false,"issuer_cik":"0001606645","issuer_name":"Foamix Pharmaceuticals Ltd.","issuer_ticker":"FOMX","issuer_name_source":null,"issuer_url":"/issuer/0001606645","owner_cik":"0001727807","owner_name":"Elliott Russell P.","owner_display_name":"Elliott Russell P.","owner_url":"/insider/0001727807","role":"Officer (VP Drug Development)","role_mark":"O","role_mark_label":"Officer (VP Drug Development)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"VP Drug Development","security_title":"Ordinary Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":142.0,"shares_display":"142","price_per_share":5.81,"price_display":"5.81","price_state":"stated","total_value":825.02,"total_display":"825.02","total_whole":"825","shares_owned_after":12442.0,"shares_owned_after_display":"12,442","ownership_form":"D","is_10b5_1":null,"transaction_date":"2018-10-01","filed_date":"2018-10-02","scope":"insider"},{"id":6229734,"accession":"0001178913-18-002030","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001178913-18-002030","line_url":"/filing/0001178913-18-002030#line-1","is_derivative":false,"issuer_cik":"0001606645","issuer_name":"Foamix Pharmaceuticals Ltd.","issuer_ticker":"FOMX","issuer_name_source":null,"issuer_url":"/issuer/0001606645","owner_cik":"0001727807","owner_name":"Elliott Russell P.","owner_display_name":"Elliott Russell P.","owner_url":"/insider/0001727807","role":"Officer (VP Drug Development)","role_mark":"O","role_mark_label":"Officer (VP Drug Development)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"VP Drug Development","security_title":"Ordinary Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":142.0,"shares_display":"142","price_per_share":5.1,"price_display":"5.10","price_state":"stated","total_value":724.2,"total_display":"724.20","total_whole":"724","shares_owned_after":12584.0,"shares_owned_after_display":"12,584","ownership_form":"D","is_10b5_1":null,"transaction_date":"2018-07-02","filed_date":"2018-07-03","scope":"insider"},{"id":6347951,"accession":"0001178913-18-001112","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001178913-18-001112","line_url":"/filing/0001178913-18-001112#line-1","is_derivative":false,"issuer_cik":"0001606645","issuer_name":"Foamix Pharmaceuticals Ltd.","issuer_ticker":"FOMX","issuer_name_source":null,"issuer_url":"/issuer/0001606645","owner_cik":"0001727807","owner_name":"Elliott Russell P.","owner_display_name":"Elliott Russell P.","owner_url":"/insider/0001727807","role":"Officer (VP Drug Development)","role_mark":"O","role_mark_label":"Officer (VP Drug Development)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"VP Drug Development","security_title":"Ordinary Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":142.0,"shares_display":"142","price_per_share":5.08,"price_display":"5.08","price_state":"stated","total_value":721.36,"total_display":"721.36","total_whole":"721","shares_owned_after":12726.0,"shares_owned_after_display":"12,726","ownership_form":"D","is_10b5_1":null,"transaction_date":"2018-04-02","filed_date":"2018-04-04","scope":"insider"},{"id":6067572,"accession":"0001178913-18-000771","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001178913-18-000771","line_url":"/filing/0001178913-18-000771#line-1","is_derivative":false,"issuer_cik":"0001606645","issuer_name":"Foamix Pharmaceuticals Ltd.","issuer_ticker":"FOMX","issuer_name_source":null,"issuer_url":"/issuer/0001606645","owner_cik":"0001727807","owner_name":"Elliott Russell P.","owner_display_name":"Elliott Russell P.","owner_url":"/insider/0001727807","role":"Officer (VP Drug Development)","role_mark":"O","role_mark_label":"Officer (VP Drug Development)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"VP Drug Development","security_title":"Ordinary Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":817.0,"shares_display":"817","price_per_share":6.14,"price_display":"6.14","price_state":"stated","total_value":5016.38,"total_display":"5,016.38","total_whole":"5,016","shares_owned_after":12868.0,"shares_owned_after_display":"12,868","ownership_form":"D","is_10b5_1":null,"transaction_date":"2018-03-02","filed_date":"2018-03-06","scope":"insider"}],"collapsed":true,"next_cursor":null,"ledger_fault":false,"count":{"value":4,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":0,"open_market":true},{"code":"S","label":"Open-market sale","n":4,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":4},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0001606645","name":"Foamix Pharmaceuticals Ltd.","url":"/issuer/0001606645","role":"Officer (VP Drug Development)","n_filings":4,"first_seen":"2018-03-06","last_seen":"2018-10-02"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001727807","retrieved_at":"2026-08-24T04:44:12+00:00","coverage":{"filings":1506293,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-21","last_ingest":"2026-08-22T05:23:40.159918+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}